ACCD
Accolade Inc
Price:  
3.48 
USD
Volume:  
605,422.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Accolade EV/EBITDA

-302.1%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Accolade Inc (ACCD) is -7.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Accolade's latest enterprise value is 316.06 mil USD. Accolade's TTM EBITDA according to its financial statements is -41.47 mil USD. Dividing these 2 quantities gives us the above Accolade EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.0x - 15.3x 11.1x
Forward P/E multiples 10.0x - 17.2x 14.4x
Fair Price (5.58) - (8.30) (7.03)
Upside -260.4% - -338.5% -302.1%
3.48 USD
Stock Price
(7.03) USD
Fair Price

Accolade EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-11 -7.97
2024-12-10 -7.93
2024-12-09 -7.89
2024-12-06 -8.03
2024-12-05 -7.74
2024-12-04 -7.72
2024-12-03 -7.80
2024-12-02 -8.22
2024-11-29 -8.36
2024-11-27 -8.15
2024-11-26 -8.19
2024-11-25 -8.24
2024-11-22 -8.05
2024-11-21 -8.07
2024-11-20 -7.78
2024-11-19 -7.64
2024-11-18 -7.43
2024-11-15 -7.60
2024-11-14 -7.85
2024-11-13 -8.01
2024-11-12 -8.07
2024-11-11 -7.97
2024-11-08 -7.78
2024-11-07 -7.78
2024-11-06 -7.49
2024-11-05 -7.10
2024-11-04 -6.98
2024-11-01 -7.08
2024-10-31 -7.02
2024-10-30 -7.39
2024-10-29 -7.27
2024-10-28 -7.43
2024-10-25 -7.06
2024-10-24 -7.06
2024-10-23 -7.08
2024-10-22 -7.39
2024-10-21 -7.43
2024-10-18 -7.66
2024-10-17 -7.82
2024-10-16 -8.15
2024-10-15 -8.15
2024-10-14 -7.99
2024-10-11 -8.22
2024-10-10 -8.38
2024-10-09 -8.44
2024-10-08 -8.71
2024-10-07 -8.57
2024-10-04 -8.15
2024-10-03 -8.01
2024-10-02 -8.19